Abstract
Four drugs, representing four different categories of cytotoxic agents, were studied for their effect on the immune response to Listeria infection in mice. The development of the host's immune response is revealed by a progressive change in the slope of the bacterial growth curve in spleen and liver. It has its onset at 24 hr in untreated mice, but in the presence of effective immunosuppression the organism multiples uninterruptedly until the animal dies from overwhelming infection. When administered as single injections at the time of infection, cyclophosphamide, vinblastine, and azathioprine all produced an effective immunosuppression, characterized by continuous bacterial multiplication. Methotrexate was also immunosuppressive, but unlike the others its effects were reversible. They could be sustained, however, by further treatment. Studies of the time-response relationship indicated that cyclophosphamide was highly active over a broad time-span ranging from 2 days before infection to 4 days after infection. Vinblastine on the other hand was maximally active when given on the day of infection, while methotrexate had its greatest effect when given 48 hr after infection. These differences indicate that these three drugs act on different cell populations involved in the host's immune response. The effects observed have been discussed in relation to what is known of the modes of action of the drugs tested. An observation of interest was the phenomenon of enhanced immunity in animals treated with cyclophosphamide or vinblastine 7–11 days before, and with methotrexate 4 days before infection; reactive hyperplasia of lymphoid tissue following withdrawal of drug was again advanced as an explanation for the occurrence of this paradoxical effect. The experimental model employed is simple, requiring only routine bacteriological facilities and minimal equipment. It seems to offer a useful means of assessing the immunosuppressive activity of drugs and of determining the time-course of their action; it could also be of value in the screening of anticancer agents.
Full Text
The Full Text of this article is available as a PDF (831.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BENACERRAF B., HALPERN B. N., BIOZZI G., BENOS S. A. Quantitative study of the granulopectic activity of the reticulo-endothelial system. III. The effect of cortisone and nitrogen mustard on the regenerative capacity of the R.E.S. after saturation with carbon. Br J Exp Pathol. 1954 Apr;35(2):97–106. [PMC free article] [PubMed] [Google Scholar]
- BERENBAUM M. C., BROWN I. N. DOSE-RESPONSE RELATIONSHIPS FOR AGENTS INHIBITING THE IMMUNE RESPONSE. Immunology. 1964 Jan;7:65–71. [PMC free article] [PubMed] [Google Scholar]
- BERENBAUM M. C. Prolongation of homograft survival in guinea pigs treated with amethopterin. Nature. 1963 May 11;198:606–607. doi: 10.1038/198606b0. [DOI] [PubMed] [Google Scholar]
- BERENBAUM M. C. The effect of cytotoxic agents on the production of antibody to T.A.B. vaccine in the mouse. Biochem Pharmacol. 1962 Jan;11:29–44. doi: 10.1016/0006-2952(62)90088-6. [DOI] [PubMed] [Google Scholar]
- Bruce W. R., Meeker B. E., Valeriote F. A. Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo. J Natl Cancer Inst. 1966 Aug;37(2):233–245. [PubMed] [Google Scholar]
- Buskirk H. H., Crim J. A., Petering H. G., Merritt K., Johnson A. G. Effect of uracil mustard and several antitumor drugs on the primary antibody response in rats and mice. J Natl Cancer Inst. 1965 Jun;34(6):747–758. [PubMed] [Google Scholar]
- CUTTS J. H., BEER C. T., NOBLE R. L. Biological properties of Vincaleukoblastine, an alkaloid in Vinca rosea Linn, with reference to its antitumor action. Cancer Res. 1960 Aug;20:1023–1031. [PubMed] [Google Scholar]
- Chanmougan D., Schwartz R. S. Enhancement of antibody synthesis by 6-mercaptopurine. J Exp Med. 1966 Sep 1;124(3):363–378. doi: 10.1084/jem.124.3.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FISCHER G. A. Increased levels of folic acid reductase as a mechanism of resistance to amethopterin in leukemic cells. Biochem Pharmacol. 1961 Jul;7:75–77. doi: 10.1016/0006-2952(61)90128-9. [DOI] [PubMed] [Google Scholar]
- HAKALA M. T., ZAKRZEWSKI S. F., NICHOL C. A. Relation of folic acid reductase to amethopterin resistance in cultured mammalian cells. J Biol Chem. 1961 Mar;236:952–958. [PubMed] [Google Scholar]
- Mackaness G. B., Blanden R. V. Cellular immunity. Prog Allergy. 1967;11:89–140. [PubMed] [Google Scholar]
- Mackaness G. B., Hill W. C. The effect of anti-lymphocyte globulin on cell-mediated reistance to infection. J Exp Med. 1969 May 1;129(5):993–1012. doi: 10.1084/jem.129.5.993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mackaness G. B. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med. 1969 May 1;129(5):973–992. doi: 10.1084/jem.129.5.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sahlar K., Schwartz R. S. The immunoglobulin sequence. II. Histological effects of the suppression of gamma-M and gamma-G antibody synthesis. Int Arch Allergy Appl Immunol. 1966;29(1):52–68. [PubMed] [Google Scholar]
- Tripathy S. P., Mackaness G. B. The effect of cytotoxic agents on the passive transfer of cell-mediated immunity. J Exp Med. 1969 Jul 1;130(1):17–30. doi: 10.1084/jem.130.1.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Werkheiser W. C. Conference on obstacles to the control of acute leukemia. Limitations on the therapeutic effectiveness of the folic acid antagonists. Cancer Res. 1965 Oct;25(9):1608–1613. [PubMed] [Google Scholar]